Walleye Trading
CLDX icon

Walleye Trading’s Celldex Therapeutics CLDX Stock Holding History

Walleye Trading’s Portfolio CLDX Stock Details CLDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-5,700
Closed -$147K – 4388
2025
Q3 		$147K Buy
+5,700
New +$132K ﹤0.01% 3530
2024
Q1 		– Sell
-4,600
Closed -$182K – 4824
2023
Q4 		$182K Buy
4,600
+3,800
+475% +$112K ﹤0.01% 3836
2023
Q3 		$22K Sell
800
-700
-47% -$21.9K ﹤0.01% 4375
2023
Q2 		$50.9K Buy
+1,500
New +$50.6K ﹤0.01% 3958
2023
Q1 		– Sell
-1,000
Closed -$44.6K – 4891
2022
Q4 		$44.6K Sell
1,000
-2,500
-71% -$89.3K ﹤0.01% 4223
2022
Q3 		$98K Buy
+3,500
New +$107K ﹤0.01% 4058
2022
Q2 		– Sell
-16,100
Closed -$548K – 5177
2022
Q1 		$548K Buy
+16,100
New +$515K ﹤0.01% 2805
2021
Q4 		– Sell
-12,800
Closed -$691K – 5400
2021
Q3 		$691K Buy
+12,800
New +$601K ﹤0.01% 2602

Other funds holding CLDX

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return